Quantedge Capital’s abrdn Life Sciences Investors HQL Stock Holding History

Quantedge Capital’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,520	Closed	-$146K	–	92
2025 Q1	$146K	Buy	+11,520	New	+$156K	0.05%	103
2024 Q4	–	Sell	-13,220	Closed	-$199K	–	171
2024 Q3	$199K	Sell	13,220 -50,200	-79%	-$760K	0.06%	170
2024 Q2	$899K	Sell	63,420 -21,700	-25%	-$293K	0.32%	78
2024 Q1	$1.16M	Sell	85,120 -38,000	-31%	-$526K	0.49%	53
2023 Q4	$1.66M	Buy	123,120 +28,700	+30%	+$353K	0.81%	35
2023 Q3	$1.18M	Buy	94,420 +35,700	+61%	+$470K	0.64%	46
2023 Q2	$795K	Buy	58,720 +33,200	+130%	+$458K	0.35%	74
2023 Q1	$355K	Buy	25,520 +8,300	+48%	+$119K	0.14%	101
2022 Q4	$245K	Buy	+17,220	New	+$249K	0.08%	144
2021 Q1	–	Sell	-18,403	Closed	-$363K	–	100
2020 Q4	$363K	Buy	+18,403	New	+$340K	0.21%	83

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Quantedge Capital's HQL Position: Q2 2025 in Review

Quantedge Capital sold out of abrdn Life Sciences Investors (HQL) in Q2 2025, closing a stake of 11,520 shares — an estimated $146K sold.

Quantedge Capital first reported a position in HQL in Q4 2020 and held it in 10 quarters. The position peaked at $1.66M in Q4 2023. 75 funds tracked by Wall St. Rank hold HQL as of Q2 2025.

Quantedge Capital reported no remaining abrdn Life Sciences Investors position as of Q2 2025 after selling out during the quarter.
Quantedge Capital sold 11,520 abrdn Life Sciences Investors shares in Q2 2025, an estimated $146K.
Quantedge Capital first reported a position in abrdn Life Sciences Investors in Q4 2020 and held it in 10 quarters.
Quantedge Capital's abrdn Life Sciences Investors position peaked at $1.66M in Q4 2023.
75 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2025.

Based on Quantedge Capital's 13F filing for Q2 2025, filed 14 Aug 2025.